KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.69 $7.28 Thursday, 25th Apr 2024 CAPR stock ended at $5.15. This is 2.18% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.72% from a day low at $4.91 to a day high of $5.24.
90 days $3.56 $7.28
52 weeks $2.68 $8.22

Historical Capricor Therapeutics prices

Date Open High Low Close Volume
Apr 25, 2024 $5.06 $5.24 $4.91 $5.15 387 923
Apr 24, 2024 $5.26 $5.65 $5.00 $5.04 912 859
Apr 23, 2024 $4.90 $5.02 $4.70 $4.82 478 266
Apr 22, 2024 $4.99 $5.11 $4.92 $4.94 356 678
Apr 19, 2024 $5.00 $5.28 $4.87 $5.01 350 273
Apr 18, 2024 $5.60 $5.65 $4.69 $5.05 929 593
Apr 17, 2024 $5.98 $6.05 $5.44 $5.55 477 863
Apr 16, 2024 $5.77 $6.03 $5.71 $5.93 275 420
Apr 15, 2024 $6.27 $6.33 $5.65 $5.86 344 629
Apr 12, 2024 $6.11 $6.29 $6.03 $6.25 165 937
Apr 11, 2024 $6.28 $6.47 $6.01 $6.23 372 616
Apr 10, 2024 $6.57 $6.71 $6.06 $6.30 311 371
Apr 09, 2024 $6.55 $6.76 $6.45 $6.60 225 814
Apr 08, 2024 $6.72 $6.80 $6.54 $6.58 121 669
Apr 05, 2024 $6.70 $6.82 $6.51 $6.72 269 053
Apr 04, 2024 $6.79 $7.00 $6.69 $6.70 238 264
Apr 03, 2024 $6.94 $7.06 $6.64 $6.80 165 530
Apr 02, 2024 $6.97 $7.07 $6.85 $6.89 189 330
Apr 01, 2024 $6.79 $7.28 $6.73 $7.10 413 944
Mar 28, 2024 $6.74 $6.94 $6.60 $6.79 185 083
Mar 27, 2024 $6.29 $7.04 $6.19 $6.77 382 685
Mar 26, 2024 $6.66 $6.68 $6.31 $6.31 336 519
Mar 25, 2024 $6.41 $6.66 $5.96 $6.63 444 333
Mar 22, 2024 $6.75 $6.76 $5.87 $6.38 740 508
Mar 21, 2024 $6.92 $7.03 $6.73 $6.88 415 170
Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT